Paroxetine Tablet, Film Coated
Product Images NDC 70518-2182

7 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Paroxetine (NDC 70518-2182). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Picture1 (Image 05)

Picture1 (Image 05)
Chemical structure diagram showing the molecular arrangement of paroxetine hydrochloride hemihydrate, the active ingredient in the product Paroxetine 30 mg film-coated tablets by RemedyRepack Inc.*
FDA Label Image

Figure (Image 06)

Figure (Image 06)
A pharmacokinetic chart showing fold change and 90% confidence intervals for the maximum concentration (Cmax) and area under the curve (AUC) of interacting drugs Pimozide 2 mg, Desipramine 100 mg, Propranolol 80 mg twice daily, Digoxin 0.25 mg once daily, and Phenytoin 300 mg. The x-axis represents change relative to reference on a logarithmic scale from 0.1 to 10.*
FDA Label Image

Figure2 (Image 07)

Figure2 (Image 07)
A pharmacokinetic fold change graph showing the effect of various interacting drugs on parameters Cmax and AUC with 90% confidence intervals. The interacting drugs listed are Cimetidine 300 mg three times daily, Phenobarbital 100 mg once daily, Phenytoin 300 mg once daily, Digoxin 0.25 mg once daily, and Diazepam 5 mg three times daily. The x-axis represents change relative to reference from 0 to 2.*
FDA Label Image

Figure 3 (Image 08)

Figure 3 (Image 08)
A pharmacokinetic (PK) chart depicting fold change and 90% confidence intervals in Cmax, Cmin, and AUC parameters for Paroxetine across different populations, including renal impairment (mild, moderate, severe), hepatic impairment, age groups over 65 years with varying doses, and gender (males). The x-axis represents change relative to reference on a logarithmic scale from 0.5 to 50.*
FDA Label Image

Mm1 (Paroxetine 30mg 70518 2182 00)

Mm1 (Paroxetine 30mg 70518 2182 00)
Paroxetine 30 mg tablet label showing a quantity of 90 tablets. The label indicates the medication is repackaged by RemedyRepack Inc., located in Indiana, PA. It includes storage instructions and the manufacturing NDC number 43547-0349-03 from Solco, Cranbury, NJ. The label also notes the prescription is for RX only.*
FDA Label Image

Mm2 (Paroxetine 30mg 70518 2182 01)

Mm2 (Paroxetine 30mg 70518 2182 01)
Paroxetine 30 mg film-coated tablets packaging label from RemedyRepack Inc. The label indicates a quantity of 30 tablets. It displays the NDC number 70518-2182-01, source NDC 43547-0349-03, and manufacturer Solco, Cranbury, NJ. The label includes storage instructions and advises to see the package insert for directions. It is marked RX only.*
FDA Label Image

Mm3 (Paroxetine 30mg 70518 2182 02)

Mm3 (Paroxetine 30mg 70518 2182 02)
Paroxetine 30 mg film-coated tablet label from RemedyRepack Inc. The label shows the product name, strength, dosage form, and quantity of 1 tablet. It includes NDC code 70518-2182-02, manufacturing location in Cranbury, NJ by Solco, and repackaging information by RemedyRepack Inc. Basic storage instructions and a QR code are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.